+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Recent advances in oral anticancer agents for colon cancer



Recent advances in oral anticancer agents for colon cancer



Future Oncology 9(12): 1893-1908



To provide therapeutic alternatives to intravenous colon chemotherapy major recent research is focusing on the development of oral chemotherapeutic agents with the intention to improve the quality of life of patients. Initially 5-fluorouracil was most commonly used for the treatment of colorectal cancer but currently oxaliplatin and irinotecan are also available. The majority of these new drugs are pyrimidines and their analogs. The rationale for using oral anticancer agents is discussed and new drugs, such as farnesyl protein transferase inhibitor S-1, rubitecan, ZD9331, MMI-166, eflornithine, sulindac, and oral camptothecin analogs, among others, are presented with the results of their preclinical and clinical developments. This article focuses on the advancement of clinical development and also discusses the relative merits and demerits of these agents. The accelerated approval of these agents by regulatory authorities is supported by survival benefit, response rate and time to progression.

(PDF emailed within 0-6 h: $19.90)

Accession: 055398292

Download citation: RISBibTeXText

PMID: 24295419

DOI: 10.2217/fon.13.137


Related references

Overview: Recent Advances in Antifolates as Anticancer Agents. Expert Opinion on Therapeutic Patents 2(12): 1979-1992, 1992

Recent Advances in Development of Polyphenols as Anticancer Agents. Mini Reviews in Medicinal Chemistry 18(15): 1265-1269, 2018

Recent Advances in Copper Intercalators as Anticancer Agents. Journal of Fluorescence 28(5): 1195-1205, 2018

Recent advances in the new generation taxane anticancer agents. Medicinal Chemistry ) 1(2): 125-139, 2006

Novel anticancer agents and targets: recent advances and future perspectives. Mini Reviews in Medicinal Chemistry 13(9): 1239-1255, 2014

Transition Metal Intercalators as Anticancer Agents-Recent Advances. International Journal of Molecular Sciences 17(11), 2016

Recent Advances of Natural and Synthetic β-Carbolines as Anticancer Agents. Anti-Cancer Agents in Medicinal Chemistry 15(5): 537-547, 2016

Recent Advances in the Development of Indazole-based Anticancer Agents. Chemmedchem 13(15): 1490-1507, 2018

Recent advances in multinuclear complexes as potential anticancer and DNA binding agents. Anti-Cancer Agents in Medicinal Chemistry 14(1): 147-169, 2014

Recent advances in the development of thioredoxin reductase inhibitors as anticancer agents. Current Drug Targets 13(11): 1432-1444, 2013

Recent advances in drug discovery of phototherapeutic non-porphyrinic anticancer agents. European Journal of Medicinal Chemistry 142: 459-485, 2017

Recent advances in pharmacologic study of natural anticancer agents in China. Memorias do Instituto Oswaldo Cruz 86 Suppl 2: 51-54, 1991

Recent Advances in the Design and Synthesis of c-Met Inhibitors as Anticancer Agents (2014-Present). Current Medicinal Chemistry 24(1): 57-64, 2016

Recent advances in the development of catalytic inhibitors of human DNA topoisomerase IIα as novel anticancer agents. Current Medicinal Chemistry 20(5): 694-709, 2014

Platinum anticancer drugs and photochemotherapeutic agents: recent advances and future developments. Science Progress 97(Pt 1): 20-40, 2014